NOTICES 
6307 
RECOMBINANT DNA MOLECULE 
PROGRAM ADVISORY COMMITTEE 
Meeting 
Pursuant to Public Law 92-463. notice 
Is hereby given of the meeting of the Re- 
combinant DNA Molecule Program Ad\ i- 
sory Committee on April 1-2. 1 DTo. 9:00 
a jn.. at the National Institutes of Health. 
Building 31. Conference Room 8. Ee- 
thesda. Maryland. This meeting will be 
open to the public on April 1. from 9:00 
aan. to 5:00 pm.. and on April 2. from 
11:00 aan. to adjournment to discuss: 
guidelines for research involving recom- 
binant DNA molecules, the status c-f re- 
search in the field, research studies re- 
quired. the mechanisms by v hich such 
studies should be supported, and the 
identification of facilities and resources 
needed in their performance. Attendance 
by the public will be limited to space 
available. 
In accordance with the provisions set 
forth in Sections 552*b)<4'. 552'b)'5> 
and 552 1 b) (6) , Title 5. US. Code and 
Section 10' d> of P.L. 92-4c3. the meet- 
ing will be closed to the public on April 2 
from 9:00 a.m. to 11:00 a m. for the re- 
view of individual Initial pending ar.d 
renewal grant proi>osals. The clo-'d por- 
tion of the meeting involves sol*.l 7 me 
internal expression of views and judg- 
ments of committee members on indi- 
vidual grant proposals containing de- 
tailed research protocols, designs, and 
other technical information: financial 
da'.a, such as salaries: and personal in- 
formation concerning individuals asso- 
ciated with the proposals. 
Dr. William. J. Gartland. Executive 
Secretary. National Institutes o: Health, 
Westwcod Building. Room 922. Bethesda. 
Maryland 20014. telephone <301' 4.°6- 
7714. will provide summaries of 'he 
meeting, rosters of committee members 
and substantive program information. 
Dated: February 6. 1976. 
Suzanne L. Fkeitemj. 
Committee Management Offi- 
cer, National institutes ol 
Health. 
|FR Doc 7G-4116 Filed 2-11-73:8. IS am] 
FEOERAl RE&ISTFR, VOt. 41, NO 30 — THURSDAY. FEBRUARY 12, 1976 
[ 573 ] 
